These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 18045684)
1. Enhancement of bone-bonding ability of bioactive titanium by prostaglandin E2 receptor selective agonist. Onishi E; Fujibayashi S; Takemoto M; Neo M; Maruyama T; Kokubo T; Nakamura T Biomaterials; 2008 Mar; 29(7):877-83. PubMed ID: 18045684 [TBL] [Abstract][Full Text] [Related]
2. Effect of a selective agonist for prostaglandin E receptor subtype EP4 (ONO-4819) on the cortical bone response to mechanical loading. Hagino H; Kuraoka M; Kameyama Y; Okano T; Teshima R Bone; 2005 Mar; 36(3):444-53. PubMed ID: 15777678 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. Tanaka M; Sakai A; Uchida S; Tanaka S; Nagashima M; Katayama T; Yamaguchi K; Nakamura T Bone; 2004 Jun; 34(6):940-8. PubMed ID: 15193540 [TBL] [Abstract][Full Text] [Related]
4. Effect of a prostaglandin EP4 receptor agonist on early fixation of hydroxyapatite/titanium composite- and titanium-coated rough-surfaced implants in ovariectomized rats. Hayashi K; Fotovati A; Abu Ali S; Nakamura Y; Inagaki M; Naito M J Biomed Mater Res A; 2010 Mar; 92(3):1202-9. PubMed ID: 19322876 [TBL] [Abstract][Full Text] [Related]
6. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model. Namikawa T; Terai H; Hoshino M; Kato M; Toyoda H; Yano K; Nakamura H; Takaoka K Spine (Phila Pa 1976); 2007 Oct; 32(21):2294-9. PubMed ID: 17906568 [TBL] [Abstract][Full Text] [Related]
7. Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist. Toyoda H; Terai H; Sasaoka R; Oda K; Takaoka K Bone; 2005 Oct; 37(4):555-62. PubMed ID: 16027058 [TBL] [Abstract][Full Text] [Related]
8. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Yoshida K; Oida H; Kobayashi T; Maruyama T; Tanaka M; Katayama T; Yamaguchi K; Segi E; Tsuboyama T; Matsushita M; Ito K; Ito Y; Sugimoto Y; Ushikubi F; Ohuchida S; Kondo K; Nakamura T; Narumiya S Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4580-5. PubMed ID: 11917107 [TBL] [Abstract][Full Text] [Related]
9. Effects on improvement of blood flow in the chronically compressed cauda equina: comparison between a selective prostaglandin E receptor (EP4) agonist and a prostaglandin E1 derivate. Sekiguchi M; Konno S; Kikuchi S Spine (Phila Pa 1976); 2006 Apr; 31(8):869-72. PubMed ID: 16622373 [TBL] [Abstract][Full Text] [Related]
10. Bone-bonding behavior of titanium alloy evaluated mechanically with detaching failure load. Takatsuka K; Yamamuro T; Nakamura T; Kokubo T J Biomed Mater Res; 1995 Feb; 29(2):157-63. PubMed ID: 7537743 [TBL] [Abstract][Full Text] [Related]
11. Topical application of statin affects bone healing around implants. Moriyama Y; Ayukawa Y; Ogino Y; Atsuta I; Koyano K Clin Oral Implants Res; 2008 Jun; 19(6):600-5. PubMed ID: 18422989 [TBL] [Abstract][Full Text] [Related]
12. Biology of alkali- and heat-treated titanium implants. Nishiguchi S; Fujibayashi S; Kim HM; Kokubo T; Nakamura T J Biomed Mater Res A; 2003 Oct; 67(1):26-35. PubMed ID: 14517858 [TBL] [Abstract][Full Text] [Related]
13. Prostaglandin EP4 receptor agonist augments fixation of hydroxyapatite-coated implants in a rat model of osteoporosis. Hayashi K; Fotovati A; Ali SA; Oda K; Oida H; Naito M J Bone Joint Surg Br; 2005 Aug; 87(8):1150-6. PubMed ID: 16049256 [TBL] [Abstract][Full Text] [Related]
14. Activation of prostaglandin E receptor EP4 subtype suppresses food intake in mice. Ohinata K; Suetsugu K; Fujiwara Y; Yoshikawa M Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):31-6. PubMed ID: 16997129 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E receptor subtype EP4 agonist protects cochleae against noise-induced trauma. Hori R; Nakagawa T; Sugimoto Y; Sakamoto T; Yamamoto N; Hamaguchi K; Ito J Neuroscience; 2009 Jun; 160(4):813-9. PubMed ID: 19303430 [TBL] [Abstract][Full Text] [Related]
16. Experimental study of bone formation around a titanium rod with beta-tricalcium phosphate and prostaglandin E2 receptor agonists. Masuzawa M; Beppu M; Ishii S; Oyake Y; Aoki H; Takagi M J Orthop Sci; 2005 May; 10(3):308-14. PubMed ID: 15928895 [TBL] [Abstract][Full Text] [Related]
17. Discovery of highly selective EP4 receptor agonists that stimulate new bone formation and restore bone mass in ovariectomized rats. Cameron KO; Lefker BA; Chu-Moyer MY; Crawford DT; Jardine PD; DeNinno SL; Gilbert S; Grasser WA; Ke H; Lu B; Owen TA; Paralkar VM; Qi H; Scott DO; Thompson DD; Tjoa CM; Zawistoski MP Bioorg Med Chem Lett; 2006 Apr; 16(7):1799-802. PubMed ID: 16442794 [TBL] [Abstract][Full Text] [Related]
18. Bone-bonding ability of a hydroxyapatite coated zirconia-alumina nanocomposite with a microporous surface. Takemoto M; Fujibayashi S; Neo M; Suzuki J; Kokubo T; Nakamura T J Biomed Mater Res A; 2006 Sep; 78(4):693-701. PubMed ID: 16739176 [TBL] [Abstract][Full Text] [Related]
19. The influence of Young's modulus of loaded implants on bone remodeling: an experimental and numerical study in the goat knee. Stoppie N; Van Oosterwyck H; Jansen J; Wolke J; Wevers M; Naert I J Biomed Mater Res A; 2009 Sep; 90(3):792-803. PubMed ID: 18615463 [TBL] [Abstract][Full Text] [Related]
20. EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures. Minamizaki T; Yoshiko Y; Kozai K; Aubin JE; Maeda N Bone; 2009 Jun; 44(6):1177-85. PubMed ID: 19233324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]